Skip to main content

This translation is provided for general access and has no recorded medical-language review.

Editorial general information — not a clinical-review record

Published: Updated: Publisher: Dr. Murat Toktamışoğlu

Before dermal filler: what should you ask about the product, area and follow-up?

A filler decision is not based only on the desired appearance. The exact product, intended area, instructions, alternatives, no-procedure option and follow-up plan should be discussed together.

This translation has no recorded clinical or medical-language review.

Direct answer

  • The product name and intended treatment area should be clear beforehand.
  • The word filler can cover different materials and risk profiles.
  • A website cannot select a fixed product, amount, area or personal suitability.

Discussing the product and area separately

Dermal filler does not mean one product or one procedure. The material, current product information, treatment area and area-specific risks should be explained together; information from another facial area cannot automatically be transferred.

Traceability and follow-up

Before treatment, you may ask about the product name, lot or serial record, intended use, alternatives, material risks and the option of no procedure. The contact route after treatment and what to do about an unusual symptom should also be clarified during the personal assessment.

Scope of this article

This content is not diagnosis, prescribing, personal risk assessment or a treatment plan. Sources may be limited to a particular product, device, task, indication or study group.

Sources and evidence limits

These links are editorial starting points used to examine the article's boundaries.

  1. Dermal Fillers (Soft Tissue Fillers)

    U.S. Food and Drug Administration (FDA) · 2023

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  2. Guideline for the Management of Hyaluronic Acid Filler-Induced Vascular Occlusion

    Gillian Murray, Cormac Convery, Lee Walker, Emma Davies; Complications in Medical Aesthetics Collaborative (CMAC) · 2021

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  3. Safety and Potential Complications of Facial Wrinkle Correction with Dermal Fillers: A Systematic Literature Review

    Audra Janovskiene, Deividas Chomicius, Dominykas Afanasjevas, Zygimantas Petronis, Dainius Razukevicius, Egle Jagelaviciene · 2024

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review

  4. Hasta Hakları Yönetmeliği

    T.C. Sağlık Bakanlığı · 2026

    Scope and limitations: Interpret this source only within the exact product, device, method, indication and study population it names. It does not establish personal suitability, Turkish authorization, a universal protocol or a guaranteed outcome; consult the full source and current local information.

    Editorial source — not a signed clinical review